Skip to main content

Schwartz Steven D's Form 4 filing

Bio-Rad Laboratories, Inc. (BIO) · filed May 1, 2024

Accession no.
0001062993-24-009134
Filed
May 1, 2024
Trade date
May 3, 2023
Filing delay
364 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $148.4K. It was filed 364 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schwartz Steven DCIK 000094080410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 3, 2023Bio-Rad A Common StockSSaleDisposed−320$463.86−$148,435.21,498.03Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)